Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC. Tegenbosch C, Vekens K. Anticancer Res 2024;44:5495-5500.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tegenbosch C, Vekens K. Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC. Anticancer Res 2024;44:5495-5500.
PMID: 39626904